Inspire Medical Systems, Inc. (INSP)
NYSE · USD · Healthcare · Medical Devices
$71.01 (-0.14%) as of
Key statistics
- Market cap
- 2.05B
- P/E (TTM)
- 15.64
- Forward P/E
- 46.22
- EPS (TTM)
- 4.54
- Dividend yield
- 0.00%
- 52-week range
- 38.91 – 147.03
- Beta
- 0.73
- Revenue (TTM)
- 898.74M
- Profit margin
- 15.03%
- Analyst target
- $68.00
- Volume
- 491.81k
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Golden Valley, MN, United States
- Employees
- 1,333
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.